-
Loading metrics
Open Access
Peer-reviewed
Research Article
Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
-
Ekaterina A. Bryushkova ,
Contributed equally to this work with: Ekaterina A. Bryushkova, Valeria D. Skatova
Roles Conceptualization, Data curation, Formal analysis, Writing – original draft
Affiliations Pirogov Russian National Research Medical University, Moscow, Russia, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia, Lomonosov Moscow State University, Moscow, Russia
⨯ -
Valeria D. Skatova ,
Contributed equally to this work with: Ekaterina A. Bryushkova, Valeria D. Skatova
Roles Data curation, Formal analysis, Visualization, Writing – original draft
Affiliations Pirogov Russian National Research Medical University, Moscow, Russia, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia
⨯ -
Zinaida Y. Mutovina,
Roles Conceptualization, Data curation, Investigation, Project administration, Supervision
Affiliation City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia
⨯ -
Alena I. Zagrebneva,
Roles Data curation, Project administration
Affiliation City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia
⨯ -
Daria S. Fomina,
Roles Conceptualization, Data curation, Investigation, Supervision
Affiliations City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
⨯ -
Tatyana S. Kruglova,
Roles Data curation
Affiliation City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia
⨯ -
Anna A. Akopyan,
Roles Data curation, Formal analysis
Affiliation Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Irina D. Strazhesko,
Roles Data curation
Affiliation Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Sergey A. Lukyanov,
Roles Funding acquisition, Project administration, Supervision, Writing – review & editing
Affiliation Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Olga N. Tkacheva,
Roles Project administration, Supervision
Affiliation Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Maryana A. Lysenko,
Roles Conceptualization, Supervision
Affiliations Pirogov Russian National Research Medical University, Moscow, Russia, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia
⨯ -
Dmitry M. Chudakov
Roles Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: chudakovdm@gmail.com
Affiliations Pirogov Russian National Research Medical University, Moscow, Russia, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia
⨯
Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
- Ekaterina A. Bryushkova,
- Valeria D. Skatova,
- Zinaida Y. Mutovina,
- Alena I. Zagrebneva,
- Daria S. Fomina,
- Tatyana S. Kruglova,
- Anna A. Akopyan,
- Irina D. Strazhesko,
- Sergey A. Lukyanov,
- Olga N. Tkacheva
- Published: August 24, 2022
- https://doi.org/10.1371/journal.pone.0273340